Literature DB >> 21917234

Endogenous fungal endophthalmitis: causative organisms, management strategies, and visual acuity outcomes.

Ahila Lingappan1, Charles C Wykoff, Thomas A Albini, Darlene Miller, Avinash Pathengay, Janet L Davis, Harry W Flynn.   

Abstract

PURPOSE: To report the causative organisms, management strategies, and visual outcomes in endogenous fungal endophthalmitis.
DESIGN: Observational case series.
METHODS: Microbiologic and medical records were reviewed retrospectively for all patients with culture-positive endogenous fungal endophthalmitis between January 1, 1990, and July 1, 2009.
RESULTS: Study criteria were met in 65 eyes of 51 patients with mean follow-up of 18 months. Yeasts were the most common causative organism in 38 (75%) patients compared with molds in 13 (25%) patients. Retinal detachment occurred in 17 eyes (26%). Visual acuity of 20/200 or better was present in 28 (56%) eyes with yeasts and in 5 (33%) eyes with molds at the last follow-up.
CONCLUSIONS: Yeasts were the most common cause of culture-proven unilateral or bilateral endogenous fungal endophthalmitis. Endogenous fungal endophthalmitis generally is associated with poor visual acuity outcomes, especially when caused by molds. Retinal detachment is a frequent occurrence during follow-up.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21917234     DOI: 10.1016/j.ajo.2011.06.020

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  57 in total

1.  Diagnostic performance of blood culture bottles for vitreous culture compared to conventional microbiological cultures in patients with suspected endophthalmitis.

Authors:  Jan Kehrmann; Valerie Chapot; Jan Buer; Philipp Rating; Norbert Bornfeld; Joerg Steinmann
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-01-09       Impact factor: 3.267

Review 2.  A comprehensive review of diagnostic imaging technologies to evaluate the retina and the optic disk.

Authors:  Asima Bajwa; Rabia Aman; Ashvini K Reddy
Journal:  Int Ophthalmol       Date:  2015-06-05       Impact factor: 2.031

3.  Response to Kato et al.: Prevalence of, and risk factors for, hematogenous fungal endophthalmitis in patients with Candida bloodstream infection.

Authors:  H Russell Day; Mark P Breazzano; Karen C Bloch; Edward F Cherney; Sean P Donahue; John B Bond
Journal:  Infection       Date:  2019-03-11       Impact factor: 3.553

4.  An Outbreak of Endogenous Fungal Endophthalmitis Among Intravenous Drug Abusers in New England.

Authors:  Aubrey R Tirpack; Jay S Duker; Caroline R Baumal
Journal:  JAMA Ophthalmol       Date:  2017-06-01       Impact factor: 7.389

5.  A British Ophthalmological Surveillance Unit Study on metastatic endogenous endophthalmitis.

Authors:  S Maling; C King; N Davies
Journal:  Eye (Lond)       Date:  2018-01-12       Impact factor: 3.775

6.  Penicillium on the Iris! An Unusual Presentation and Cause of Postoperative Anterior Uveitis.

Authors:  Vijaya Jojo; Minakshi Gupta; Bharti Sharma; Poonam Singh; Nitin Dhira
Journal:  Cureus       Date:  2019-08-07

7.  Endophthalmitis: A review of recent trends.

Authors:  Janice R Safneck
Journal:  Saudi J Ophthalmol       Date:  2012-03-03

8.  Endogenous Endophthalmitis.

Authors:  Emmett T Cunningham; Harry W Flynn; Nidhi Relhan; Manfred Zierhut
Journal:  Ocul Immunol Inflamm       Date:  2018       Impact factor: 3.070

9.  [Iris tumor of unknown origin].

Authors:  J Rueping; A Klingenstein; J Wagener; A Kampik; D Kook
Journal:  Ophthalmologe       Date:  2013-12       Impact factor: 1.059

10.  Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.

Authors:  Peter G Pappas; Carol A Kauffman; David R Andes; Cornelius J Clancy; Kieren A Marr; Luis Ostrosky-Zeichner; Annette C Reboli; Mindy G Schuster; Jose A Vazquez; Thomas J Walsh; Theoklis E Zaoutis; Jack D Sobel
Journal:  Clin Infect Dis       Date:  2015-12-16       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.